These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24182853)

  • 1. Treatment of juvenile idiopathic arthritis in the biologic age.
    Stoll ML; Cron RQ
    Rheum Dis Clin North Am; 2013 Nov; 39(4):751-66. PubMed ID: 24182853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological therapy treatment of juvenile idiopathic arthritis].
    Herlin T
    Ugeskr Laeger; 2008 Jun; 170(24):2105-8. PubMed ID: 18565289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile idiopathic arthritis: therapies in the 21st century.
    Haines KA
    Bull NYU Hosp Jt Dis; 2007; 65(3):205-11. PubMed ID: 17922671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies in juvenile rheumatoid/idiopathic arthritis.
    Passo M
    Curr Probl Pediatr Adolesc Health Care; 2006 Mar; 36(3):97-103. PubMed ID: 16473286
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapies in rheumatologic disorders.
    Miller AV; Ranatunga SK
    Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologicals in the treatment of rheumatic diseases].
    Scherer HU; Burmester GR
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials reveal promising options for treating juvenile rheumatoid arthritis.
    Hampton T
    JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
    Otten MH; Anink J; Spronk S; van Suijlekom-Smit LW
    Ann Rheum Dis; 2013 Nov; 72(11):1806-12. PubMed ID: 23172748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of biologicals in the treatment of SoJIA].
    Dückers G; Niehues T
    Z Rheumatol; 2010 Aug; 69(6):505-15. PubMed ID: 20668866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New ways in the management of rheumatoid arthritis in Hungary].
    Gergely P; Poór G
    Lege Artis Med; 2007 Oct; 17(10):657-64. PubMed ID: 19227595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biologic response modifiers for juvenile idiopathic arthritis].
    Yokota S
    Nihon Rinsho; 2007 Jul; 65(7):1331-5. PubMed ID: 17642252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y; Imanaka H; Nonaka Y; Takei S
    Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.
    Shenoi S; Wallace CA
    Paediatr Drugs; 2010 Dec; 12(6):367-77. PubMed ID: 21028916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological treatment in severe Still's disease--a case report].
    Suszek D; Koszarny A; Jeleniewicz R; Majdan M; Bończak A; Czukiewska A; Koszła B; Kurlej S; Markowicz J; Szymczyk A
    Wiad Lek; 2015; 68(1):104-7. PubMed ID: 26094343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile idiopathic arthritis: current and future treatment options.
    Martini G; Zulian F
    Expert Opin Pharmacother; 2006 Mar; 7(4):387-99. PubMed ID: 16503811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.
    Liu SW; Velez NF; Lam C; Femia A; Granter SR; Townsend HB; Vleugels RA
    JAMA Dermatol; 2013 Oct; 149(10):1204-8. PubMed ID: 23986394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
    Gibbons LJ; Hyrich KL
    BioDrugs; 2009; 23(2):111-24. PubMed ID: 19489652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution.
    Kuek A; Hazleman BL; Ostör AJ
    Postgrad Med J; 2007 Apr; 83(978):251-60. PubMed ID: 17403952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.